Mast Therapeutics, Inc. 4
4 · Mast Therapeutics, Inc. · Filed Jun 21, 2013
Insider Transaction Report
Form 4
Vetticaden Santosh
Chief Medical Officer & SVP
Transactions
- Award
Employee Stock Option (Right to Buy)
2013-06-19+125,000→ 125,000 totalExercise: $0.50Exp: 2023-06-19→ Common Stock (125,000 underlying)
Footnotes (1)
- [F1]This option vests and becomes exercisable as to 5,208 shares on September 5, 2013, which is the first anniversary of the reporting person's employment with the issuer, and as to approximately 1/48th of the balance of the shares subject to this option on October 5, 2013 and each monthly anniversary thereafter such that all of the shares subject to this option will have fully vested and become exercisable as of September 5, 2017, subject to continued service with the issuer.